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Background: To observe the outcome of implementation of Ramadan-specific diabetes management recommendations
in fasting individuals with diabetes through health care providers.
Methods: This multi-centered prospective study was conducted at nine diabetes specialist centers in four provinces of
Pakistan. The study was carried out in two phases; pre-Ramadan recruitment interview (visit A) and post-Ramadan follow
up interview (visit B) of the same patients. Pre-Ramadan individual counseling was given and educational material
provided to each patient by health care providers during visit A.
Results: Out of 388 patients with diabetes, blood glucose level was checked by all patients with type 1 and 71.43%
patients with type 2 diabetes when they developed hypoglycemic symptoms during Ramadan. Of patients with type 1
and type 2 diabetes, 33.33% and 48% discontinued their fast when they felt hypoglycemic symptoms, respectively. None
of the patient with type 1, while 18.87% patients with type 2 diabetes discontinued fast on the development of
hyperglycemic symptoms. Drug dosage and timing were altered in 80% patients with type 1 and 90.5% patients with
type 2 diabetes during Ramadan. Majority of the patients with type 2 diabetes changed from moderate/severe levels of
physical activity before Ramadan to light physical activity during Ramadan (p<0.000). None of the patients required
hospitalization when they developed symptomatic hypoglycemia or hyperglycemia and none developed diabetic
ketoacidosis and hyperglycemic hyperosmolar state during Ramadan.
Conclusion: We observed that it is practicable to implement Ramadan-specific diabetes management recommendations
through health care providers.
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Fasting in Ramadan is one of the five pillars of Islam [1].
Ramadan is the ninth lunar month of the Islamic calendar
and its duration varies between 29 and 30 days [2]. All
healthy adult Muslims are obligated to fast during Ram-
adan each year. However, if the health of the individual is
adversely affected by fasting, Islam exempts that individual
from holding fast for as many days as necessary [3].
During fasting, Muslims must abstain from taking food,
water, beverages, smoking and oral medications from sun-
rise to sunset. However, there is no restriction on the* Correspondence: myakoob@bideonline.com
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article, unless otherwise stated.intake of food or fluid between sunset and dawn [4]. The
length of daylight hours and the duration of the fast vary
considerably between summer and winter months, as
Ramadan occurs 11 days earlier each year and hence every
9 years it occurs in a different season [5].
According to the 2009 estimates, Muslims constitute
1.57 billion of the world’s population and growing by 3%
per year [6]. Globally, around 50 million Muslims with
diabetes fast during the month of Ramadan each year
[7]. The population based study, Epidemiology of Dia-
betes and Ramadan (EPIDIAR), highlighted certain im-
portant facts regarding fasting and diabetes management
during Ramadan. The study was conducted in 12,243 pa-
tients with diabetes in 13 Islamic countries. It showedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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betes reported fasting during Ramadan. Only 68% and 62%
of the patients with type 1 and type 2 diabetes received
Ramadan-specific diabetes management recommendations
from health care providers. Blood glucose monitoring dur-
ing Ramadan was done by only 67% and 37% of the pa-
tients with type 1 type 2 diabetes, respectively [1].
Interestingly, oral anti diabetic drug doses were continued
unchanged in 79% and 75% patients with type 1 and type 2
diabetes, respectively. Whereas, insulin dose was continued
unchanged in 64% of the patients with diabetes (both type
1 and type 2 diabetes). The frequency of at least one epi-
sode of severe hypoglycemia requiring hospitalization dur-
ing Ramadan for patients with type 1 and type 2 diabetes
was 9% and 2%, respectively. Similarly the frequency of at
least one episode of severe hyperglycemia with/without
ketoacidosis requiring hospitalization during Ramadan for
patients with type 1 and type 2 diabetes was 13% and 4%,
respectively. Physical activity, sleep duration, food intake,
fluid intake and sugar intake during Ramadan were chan-
ged by only one half of the study population [1].
Based on these findings several recommendations were
made by experts in the field of diabetes. Education of pa-
tients was identified as the cornerstone of safe fasting.
Ramadan-specific education including drug dosage and
timing alteration, blood glucose monitoring and dietary
changes were identified as main factors to avoid acute
complications of diabetes during Ramadan [1,3,4,8-11].
To the best of our knowledge no study was conducted
to observe the implementation of these recommen-
dations in a multi-centered setting. Hence, a multi-
centered prospective study was designed. The aim of the
study was to observe the outcome of the implementation
of Ramadan-specific diabetes management recommen-
dations in fasting individuals with diabetes through
health care providers.
Patients and methods
This prospective study was conducted at nine diabetes
specialist centers in four provinces of Pakistan. The
study was carried out in two phases; a pre-Ramadan re-
cruitment interview (visit A) and a post-Ramadan follow
up interview (visit B) of the same patients. Visit A com-
menced 15 days prior to Ramadan of 2011 (Hijri year,
1432) and continued until the first day of Ramadan,
2011. The second interview (visit B) was performed up
to one month after the end of Ramadan, 2011. At each
center; randomly selected health care providers (diabe-
tologists or diabetes educators), involved in the care of
patients with diabetes were assigned the task to enroll
patients for the study after obtaining informed consent.
Ethical approval for the study was obtained from the In-
stitutional Review Board of Baqai Institute of Diabetol-
ogy & Endocrinology (BIDE).Inclusion criteria
All subjects with type 1 or type 2 diabetes who gave his-
tory of fasting in the previous year and showed intention
to fast in the coming Ramadan, were considered eligible
to participate in the study.
Exclusion criteria
Patients with type 1 or type 2 diabetes with serious com-
plications, such as unstable angina, uncontrolled hyper-
tension, severe liver or renal disease, newly diagnosed
patients (< 3 month), pregnant women, patients with
brittle type 1 diabetes, elderly patients with alertness
problems, hospitalized individuals and patients with dia-
betes with hypoglycemia unawareness were excluded
from the study.
Patient counseling
The methodology of the study was explained and uni-
form recommendations and educational material regard-
ing the information to be communicated to the patients
at the time of recruitment in the study were presented
to each health care provider (diabetologists or diabetes
educators) before the start of the study. They were ad-
vised to assess the patient’s physical well-being and
metabolic control at the time of recruitment in the
study. An identical questionnaire was used at each
center.
Pre-Ramadan individual counseling was given to each
patient by the health care providers during visit A. The
counseling session usually lasted for 15–20 min. Patients
were educated regarding recognition of warning symp-
toms of possible complications such as hypoglycemia,
hyperglycemia and dehydration. They were told to moni-
tor blood glucose at home according to their usual rou-
tine and also when they experienced any hypo or
hyperglycemic symptoms. Patients were advised to dis-
continue their fast immediately for the rest of the day in
the case of any medical emergency and to seek medical
care. Patients were also encouraged to continue their
routine physical activities, although they were advised to
avoid non routine heavy physical activity during fasting.
Each patient was also provided written educational ma-
terial regarding Ramadan-specific diabetes management
recommendations.
The physicians (diabetologists) were recommended to
adjust drug dosage and timing in fasting patients with dia-
betes. The advice to the patients was to take 75% of their
full pre-Ramadan morning dose of oral hypoglycemic
agents such as sulphonylureas, meglitinides as well as in-
sulin, (alone or in combination) at Iftar (pre-dusk) and half
of the pre-Ramadan evening dose at Sehar (pre-dawn).
The rest of the oral hypoglycemic agents like metformin,
thiazolidinedione and acarbose could be continued as
their full pre-Ramadan morning dose of oral hypoglycemic
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Ramadan evening dose at Sehar (pre-dawn). However, the
decision for altering the medication regimen was at the
physician’s discretion, depending on the glycemic control
of individual patients.
Data collection
Two standardized questionnaire-based interviews were
conducted by the physicians who enrolled the study sub-
jects during face-to-face interviews.
Pre-Ramadan interview (visit A)
In the visit A, detailed history was taken from the pa-
tient. Information collected included socio-demographic
and anthropometric data, diabetes type, duration of the
disease, comorbidities, frequency and type of current
treatment of diabetes, diet, physical activity level includ-
ing type of exercise and routine blood glucose monitor-
ing practices. Laboratory investigations including fasting
blood glucose, HbA1c and fasting lipid profile were also
collected from the patient’s record (if available within
3 months).
Post-Ramadan follow up interview (visit B)
In the visit B information collected included anthropo-
metric data, number of days of fasting during Ramadan,
development of symptoms of hypoglycemia and hyper-
glycemia and if developed, the frequency of the symp-
toms and the measures taken, hospital admission for any
medical reason, frequency of blood glucose monitoring
during Ramadan, frequency and type of treatment of
diabetes during Ramadan and physical activity level in-
cluding type of exercise during Ramadan.
Symptomatic hypoglycemia
Symptomatic hypoglycemia was defined as the occur-
rence of one or few of the hypoglycemic symptoms such
as palpitation, shivering, cold sweating, feelings of weak-
ness, excessive hunger, visual problems, drowsiness and
unconsciousness [12].
Symptomatic hyperglycemia
Symptomatic hyperglycemia was defined as the occur-
rence of one or few of the hyperglycemic symptoms such
as polyphagia, polydipsia, frequent urination, drowsiness
and unconsciousness [12].
All the data was centralized into the computer data
base of Baqai Institute of Diabetology & Endocrinology
(BIDE). A total of 682 patients initially enrolled in the
study (visit A). Of these 388 (56.89%) completed the fol-
low up interview (visit B). Individuals with diabetes who
did not attend the follow up interview (visit B) within
the stipulated time period of one month after Ramadan
were excluded from the final analysis.Statistical analysis
Data analysis was conducted on Statistical Package for So-
cial Sciences (SPSS), version 13.0. All the continuous vari-
ables, i.e. age, duration of diabetes, waist circumference,
weight, height, body mass index (BMI), systolic and dia-
stolic blood pressure, fasting blood sugar, HbA1c, choles-
terol, HDL, LDL and triglycerides, were presented as
Mean±SD. Categorical variables, such as gender, education
level, occupation, physical activity level and treatment mo-
dality were presented in the form of number and percent-
age. A paired t-test was utilized to find the difference in
mean values and chi square was used for categorical vari-
ables. P<0.05 was considered statistically significant.
Results
A total of 682 patients with diabetes (325 males and 357
females) attended the pre-Ramadan recruitment inter-
view (visit A). Of these, there were 27 (3.95%) and 655
(96.04%) patients with type 1 and type 2 diabetes re-
spectively. Table 1 shows the baseline demographic and
biochemical characteristics of the studied population.
Mean age of the patients with type 1 diabetes was
24.50±9.80 years whereas; patients with type 2 diabetes
were older with the mean age of 53.24±10.73 years. Mean
duration of diabetes in patients with type 1 and type 2 dia-
betes was 8.53±6.56 and 8.85±6.84 years respectively.
Mean BMI was 22.02±4.13 kg ⁄m2 in patients with type 1
and 28.78±6.93 kg ⁄m2 in patients with type 2 diabetes.
Mean HbA1c was 9.69±2.37 and 8.67±1.87% in patients
with type 1 and type 2 diabetes respectively. All the patients
with type 1 diabetes were on insulin. Oral hypoglycemic
agents was the treatment regimen in 52.40% patients with
type 2 diabetes, whereas 30.30% patients were taking a
combination of oral hypoglycemic agents and insulin and
17.30% patients were on insulin.
Waist circumference was found unchanged in 31.25%
patients with type 1, increased in 43.75% and decreased
in 25% of the patients with type 1 diabetes after Ram-
adan. In patients with type 2 diabetes, waist circumfer-
ence was unchanged in 18.68%, increased in 39.93% and
decreased in 41.39% of the patients. It was also observed
that weight remained unchanged in 50% patients, in-
creased in 20% and decreased in 30% of the patients
with type 1 diabetes after Ramadan. In patients with type
2 diabetes weight remained unchanged in 34.78% pa-
tients, increased in 26.36% and decreased in 38.86% pa-
tients with type 2 diabetes after Ramadan.
However, no statistically significant difference (p>0.05)
was observed in mean waist circumference, weight, BMI,
systolic and diastolic blood pressures before and after
Ramadan in patients with type 1 and type 2 diabetes, as
shown in Table 2.
In patients with type 1 diabetes drug dosage and tim-
ing were altered in 16 (80%) patients during Ramadan
Table 1 Baseline demographic and biochemical






n 27 655 682
Male 12 (44.40%) 313 (47.80%) 325 (47.65%)
Female 15 (55.60%) 342 (52.20%) 357 (52.34%)
Age (years) 24.50±9.80 53.24±10.73 52.08±12.05
Duration of diabetes (years) 8.53±6.56 8.85±6.84 8.84±6.83
Waist circumference (cm) 78.18±8.31 97.28±11.62 96.49±12.11
Weight (kg) 57.35±11.42 72.42±13.18 71.83±13.44
Height (cm) 161.10±11.52 159.38±11.02 159.45±11.03




6 (22.20%) 230 (35.20%) 236 (34.70%)
Secondary education 14 (51.90%) 212 (32.50%) 226 (33.23%)
Higher education/university
level
7 (25.90%) 211 (32.30%) 218 (32.05%)
Occupation
Manual labor 1 (3.80%) 70 (10.80%) 71 (10.55%)
Office employee 22 (84.60%) 482 (74.50%) 504 (74.88%)
Retired/unemployed 3 (11.50%) 95 (14.70%) 98 (14.56%)
Physical activity
Sedentary/light activity 12 (66.70%) 282 (81.50%) 294 (80.77%)
Moderate physical activity 3 (16.70%) 61 (17.60%) 64 (17.58%)
Heavy physical activity 3 (16.70%) 3 (0.90%) 6 (1.65%)
Type of treatment
Oral hypoglycemic agents 0 (0%) 339 (52.40%) 339 (50.29%)
Insulin 27 (100%) 112 (17.30%) 139 (20.62%)
Oral hypoglycemic agents+Insulin 0 (0%) 196 (30.30%) 196 (29.08%)
Systolic blood pressure (mmHg) 111.15±14.23 127.31±18.33 126.69±18.45
Diastolic blood pressure (mmHg) 75.93±7.34 79.55±10.24 79.41±10.16
Fasting blood sugar (mmoles/l) 9.24±4.02 8.59±3.02 8.57±3.08
HbA1c (mmol/mol) 82±2 71±−3 72±−3
HbA1c (%) 9.69±2.37 8.67±1.87 8.71±1.89
Fasting serum cholesterol (mmol/l) 4.13±0.8986 4.526±1.19 4.507±1.18
Fasting serum triglyceride (mmol/l) 0.98±0.715 1.83±1.43 1.79±1.422
Fasting serum HDL cholesterol
(mmol/l)
1.068±0.136 1.046±0.402 1.047±0.39
Fasting serum LDL cholesterol
(mmol/l)
2.36±0.928 2.65±1.01 2.64±1.01
Values are Mean±SD; n (%).
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patients with type 2 diabetes drug dosage and timing
were changed in 325 (90.5%) patients, while it remained
unchanged in 34 (9.5%) patients (p<0.000).
No significant change (p>0.05) in the level of physical
activity was observed in patients with type 1 diabetes
during Ramadan. However, in patients with type 2 dia-
betes, majority of the patients changed from moderate/severe levels of physical activity before Ramadan to light
physical activity during Ramadan (p<0.000).
Table 3 shows the frequency of symptomatic hypo-
glycemia and hyperglycemia in the studied subjects dur-
ing Ramadan. Overall, symptomatic hypoglycemia was
observed in 92 (23.7%) patients; in 6 (35.29%) patients
with type 1 and 86 (23.18%) patients with type 2 dia-
betes. Blood glucose level was checked by all the patients
with type 1 and 71.43% patients with type 2 diabetes
when they developed hypoglycemic symptoms during
Ramadan. On the development of hypoglycemic symp-
toms, 33.33% patients with type 1 and 48% patients with
type 2 diabetes discontinued their fast respectively. Simi-
larly, overall hyperglycemic symptoms were felt by 59
(16.30%) patients; in 6 (33.33%) patients with type 1 and
53 (15.41%) patients with type 2 diabetes. All the pa-
tients with type 1 and 78% patients with type 2 diabetes
checked their blood glucose level on the development of
hyperglycemic symptoms. None of the patient with type
1 diabetes discontinued their fast when they felt hyper-
glycemic symptoms, while 18.87% patients with type 2
diabetes discontinued the fast on the development of
hyperglycemic symptoms. None of the patients with type
1 and type 2 diabetes required hospitalization when they
developed either symptomatic hypoglycemia or hyper-
glycemia. The mean blood glucose level at which pa-
tients with type 1 and type 2 diabetes discontinued their
fast on the development of hypoglycemic symptoms was
3.33 mmol/l and 3.62±0.87 mmol/l respectively. Simi-
larly, patients with type 2 diabetes also discontinued
their fast on the development of hyperglycemic symp-
toms at mean blood glucose level of 17.05±3.49 mmol/l.
None of the patients developed diabetic ketoacidosis and
hyperglycemic hyperosmolar state.
Discussion
In this study we observed that it is feasible to implement
Ramadan-specific diabetes management recommenda-
tions in fasting individuals with diabetes. None of the
fasting patients with type 1 and type 2 diabetes required
hospitalization for any acute complications of diabetes
during Ramadan.
Ramadan-specific patient education is considered a
keystone for safe fasting in individuals with diabetes. In
our previous study, we observed that with patient educa-
tion, alteration of drug dosage and timing, dietary coun-
seling and active glucose monitoring, the majority of the
patients did not have any serious acute complications of
diabetes during Ramadan [8]. Similar results were ob-
served in the present study in a multi-centered setting.
Blood glucose monitoring during Ramadan is essential
for patients with diabetes who hold fast during Ramadan
and more particularly in patients with type 1 diabetes
and also in patients with type 2 diabetes who require
Table 2 Changes in waist, weight, body mass index and blood pressure before and after Ramadan (n=388)














Waist circumference (cm) 78.70±7.94 77.77±9.37 0.376 98.96±14.44 98.19±12.09 0.219 97.05±12.83 97.84±14.89 0.190
Weight (kg) 58.95±18.45 56.65±11.92 0.392 72.89±13.37 73.31±13.67 0.096 72.45±14.06 72.03±14.37 0.178
Body mass index (kg/m²) 24.16±10.18 21.80±3.70 0.192 28.91±5.91 28.93±5.94 0.835 28.65±6.30 28.54±6.06 0.400
Systolic blood pressure (mmHg) 107.36±14.84 108.42±13.85 0.749 126.59±16.96 127.81±17.56 0.155 126.87±17.88 125.65±17.35 0.144
Diastolic blood pressure (mmHg) 75.50±15.03 74.75±7.52 0.769 79.25±9.74 79.23±10.55 0.966 79.0±10.46 79.06±10.09 0.906
Values are Mean±SD. p<0.05 considered statistically significant.
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followed the advice of monitoring their blood glucose
when they felt hypoglycemic or hyperglycemic symp-
toms during fasting.
It has been recommended that patients with diabetes
should immediately discontinue their fast on the develop-
ment of hypoglycemia (blood glucose of <3.3 mmol/l [60
mg/dl]) because their blood glucose may fall further if
treatment is delayed. Moreover, fast should also be broken
if blood glucose reaches <3.9 mmol/l [70 mg/dl] with in
the first few hours of starting the fast [4]. If blood glucose





Checked blood glucose level if developed symptoms of hypoglycemia
No 0 (0%)
Yes 6 (100%)
If developed symptoms of hypoglycemia
Continued fast 4 (66.67%)
Discontinued fast 2 (33.33%)
Visited doctor 0 (0%)




Checked blood glucose level if developed symptoms of hyperglycemia
No 0 (0%)
Yes 6 (100%)
If developed symptoms of hyperglycemia
Continued fast 6 (85.71%)
Discontinued fast 0 (0%)
Visited doctor 1 (14.29%)
Needed hospitalization 0 (0%)
Values are n (%).discontinued for the rest of the day [4]. In the present
study, many individuals with diabetes followed the advice
and broke their fast if blood glucose readings were either
too low or very high which may have enabled them to pre-
vent acute complications of diabetes during Ramadan.
Drug dosage and timing alteration during Ramadan is
also suggested in studies and recommendations [4,8]. In
this study, the advice was followed and drug dosage and
timing were changed in the majority of the patients with
type 1 and type 2 diabetes during Ramadan.
Studies have shown variable results regarding weight
and BMI changes in patients with diabetes duringlycemia during Ramadan
s Type 2 diabetes Overall
285 (76.82%) 296 (76.3%)
86 (23.18%) 92 (23.7%)
22 (28.57%) 22 (26.50%)
55 (71.43%) 61 (73.49%)
38 (50.67%) 42 (51.85%)
36 (48%) 38 (46.91%)
1 (1.33%) 1 (1.23%)
0 (0%) 0 (0%)
291 (84.59%) 303 (83.70%)
53 (15.41%) 59 (16.30%)
11 (22%) 11 (19.64%)
39 (78%) 45 (80.35%)
43 (81.13%) 49 (81.67%)
10 (18.87%) 10 (16.67%)
0 (0%) 1 (1.67%)
0 (0%) 0 (0%)
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weight and BMI during Ramadan [13,14]. However, no sig-
nificant change in mean body weight and body mass index
was observed in this study before and after Ramadan, simi-
lar to the findings of other studies [5,15,16]. This may be at-
tributed to the positive effects of dietary and life style
changes as advised during Ramadan.
Data regarding physical activities in fasting patients
with diabetes during Ramadan is scarce. Studies have
emphasized that light to moderate levels of physical ac-
tivity on a regular basis during fasting is harmless for pa-
tients with type 2 diabetes [5]. Normal levels of physical
activity may be continued. However, excessive physical
activity should be avoided within the few hours of sunset
meal as it may lead to an increased risk of hypoglycemia
[4]. In this study majority of the patients with type 2 dia-
betes followed the advice and changed from moderate/
severe levels of physical activity before Ramadan to light
physical activity during Ramadan.
As fasting itself is a hypoglycemia prone condition, the
prevalence of symptoms related to hypoglycemia was high
(23.7%) in the present study, majority of these episodes
were mild hypoglycemic episodes. However, none of
the patients required hospitalization for symptomatic
hypoglycemic episodes during Ramadan which may be the
result of Pre - Ramadan patient education. The overall
prevalence of symptomatic hyperglycemia in the present
study was 16.30%, nearly identical to a retrospective study
[12]. Although risk for hypoglycemia is the major concern
for patients with diabetes during Ramadan, excessive con-
sumption of sweet and fried food, especially at Iftar meal
predispose the patients to hyperglycemia [17]. However,
as a benefit of patient education regarding diet during
Ramadan none of the patients in the study developed dia-
betic ketoacidosis and hyperglycemic hyperosmolar state.
Our study has some limitations; sample size was small
and there was no control group i.e. individuals with dia-
betes without Ramadan-specific patient education. There
was also no Pre and Post Ramadan data for comparison
with the findings during Ramadan. Dropout rate in the
study was high because individuals who did not attend
the follow up interview (visit B) within the stipulated
time period of one month after Ramadan were not in-
cluded in the final analysis.
Conclusion
We observed that it is practicable to implement Ramadan-
specific diabetes management recommendations through
health care providers. Patients with diabetes who intend to
fast should undergo Pre-Ramadan assessment and receive
appropriate highly individualized patient education. Health
care providers should also be educated and trained to de-
liver appropriate advice in order to ensure safe fasting in
patients with diabetes during Ramadan.Competing interests
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